Also trades as: HEAL.CN (CNQ) · $vol 0M
NMLSF OTC
Restart Life Sciences Corp.
1W: +32.8%
1M: +11.8%
3M: +1.0%
YTD: -19.6%
1Y: +83.8%
3Y: -89.5%
5Y: -96.8%
$0.07
+0.00 (+7.03%)
Weekly Expected Move ±34.7%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$72K
+74.1% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$72K
+74.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$3K
-99.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$23M | -$3M | -$2M | -$1M | $225K |
| Depreciation & Amort. | $7K | $5K | $4K | $3K | $2K |
| Stock-Based Comp. | $894K | $348K | $328K | $353K | $32K |
| Change in Working Capital | $25K | $630K | -$2K | $4K | $277K |
| Other Non-Cash Items | $17M | -$133K | -$72K | $586K | -$609K |
| Operating Cash Flow | -$857K | -$2M | -$1M | -$278K | -$72K |
| — Investing Activities — | |||||
| Capital Expenditures | $434K | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $3M | $0 | $0 | $0 | $0 |
| Investment Purchases | -$434K | $0 | $0 | $0 | $0 |
| Investment Sales | $733K | $30K | $0 | $0 | $0 |
| Other Investing | -$434K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $3M | $30K | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $75K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $8K | $19K | $0 |
| Financing Cash Flow | $0 | $0 | $1M | $19K | $75K |
| Net Change in Cash | $2M | -$2M | $48K | $716K | $3K |
| Cash End of Period | $2M | $219K | $267K | $8K | $11K |
| Free Cash Flow | -$422K | -$2M | -$1M | -$278K | -$72K |